Abramson Cancer Center of the University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
NCT Number: NCT02250053
Despite the success of surgery and chemotherapy among people with colon cancer, 30-50% of patients develop recurrent disease. Physical activity has emerged as a potential lifestyle intervention to reduce cancer recurrence and improve survival among people with colon cancer (CC). This pilot study aims to identify the dose-response effects of aerobic exercise on molecular and cellular pathways associated with physical activity and CC outcomes among patients with stage II and III CC.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Philadelphia, Pennsylvania, 19104, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 2 years
Time frame: 6 months
Time frame: 6 months
Time frame: six months
Time frame: six months
Abramson Cancer Center at Penn Medicine
Other
The COURAGE Trial: Colon Recurrence and Aerobic Exercise: A Feasibility Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04164069
Advanced Colorectal Carcinoma, Bile Duct Cancer
Columbus, Ohio, United States
View Trial DetailsNCT02129218
Colonic Diseases, Colonic Neoplasms
Cleveland, Ohio, United States
View Trial DetailsNCT00433576
Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum
Ann Arbor, Michigan, United States
View Trial DetailsNCT00004931
Colonic Diseases, Colonic Neoplasms
Pittsburgh, Pennsylvania, United States
View Trial Details